Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy
Authors:
Open Access
- 5 September 2003
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 18 (6) , 549-558
Abstract
Type 1 diabetes mellitus is the result of an autoimmune process characterized by pancreatic beta cell destruction. It has been reported that chronic hepatitis C infection is associated with type 2 di...Keywords
This publication has 70 references indexed in Scilit:
- Prospects for the Prevention and Reversal of Type 1 Diabetes MellitusDrugs, 2002
- Induction of multiple autoantibodies to islet cell antigens during treatment with interferon alpha for chronic hepatitis CGut, 2001
- Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.Diabetes Care, 2000
- Effects of long-term interferon-α treatment on glucose tolerance in patients with chronic hepatitis CJournal of Hepatology, 1999
- Interferon-α and Development of Type 1 DiabetesDiabetes Care, 1998
- Diabetes Mellitus and Interferon TherapyDiabetic Medicine, 1997
- Side effects of high-dose interferon therapy for chronic hepatitis CJournal of Hepatology, 1996
- Interferon-α therapy May induce insulin autoantibody development in patients with chronic viral hepatitisDigestive Diseases and Sciences, 1996
- A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferonJournal of Hepatology, 1996
- Reversible diabetes in patient with AIDS-related Kaposi's sarcoma treated with interferon α-2aThe Lancet, 1995